NCT00128778 2023-03-06
Maintenance Treatment With Liposomal Doxorubicin (Caelyx) in Metastatic Breast Cancer Patients
Spanish Breast Cancer Research Group
Phase 4 Completed
Clinical Trials
5 trialsNCT05302336 2022-04-14
AC vs TC in Patients With HR-positive, HER2-negative Early Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 4 Unknown
NCT00604968 2017-06-07
Pegylated Liposomal Doxorubicin (Caelyx(R)) as Monotherapy in Elderly Patients With Locally Advanced and/or Metastatic Breast Cancer (Study P05059)
Merck Sharp & Dohme LLC
Phase 4 Terminated
NCT00779285 2015-07-14
Safety Study of CAELYX in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines (Study P04057)(TERMINATED)
Merck Sharp & Dohme LLC
Phase 4 Terminated
NCT00531973 2009-02-18
LITE
Catholic University, Italy
Phase 4 Unknown